Andreas Schneeweiß

机构：German Cancer Research Center, Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases · ORCID：0000-0002-2429-4512

发表论文 1657 篇 · 总被引 54676 次 · h-index 102

代表论文

• Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials (2025 · The Lancet Oncology · 被引 6)
• Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo Trial (2026 · Journal of Clinical Oncology · 被引 2)
• Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study (2025 · ESMO Open · 被引 1)
• Assessment of Cancer‐Related Cognitive Impairments Across Anti‐Cancer Therapies in a Predominantly Breast Cancer Cohort (2026 · International Journal of Cancer)
• Surgical axillary intervention after neoadjuvant systemic therapy (NST) for early-stage breast cancer – Clinical significance of micrometastases: Data from five neoadjuvant studies (2026 · The Breast)
• AGO Breast Panel Recommendations for the use of treatment-relevant biomarkers in early and advanced breast cancer—2026 Update (2026 · The Breast)